BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
BIOTRICITY INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026
- Market cap
- $1.15M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.5900 (−92.19%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
BIOTRICITY INC. grew revenue 13.4% to $16.40M over the twelve months to Jun 30, 2026.
Revenue
$16.40M
+13.4% vs. a year earlier
Operating income
$1.57M
TTM Q1 2027
EPS, diluted
-$0.14
TTM Q1 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.15M
- P/E ratio
- –
- Price to sales
- 0.07
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $16.40M
- Net income
- -$2.69M
- EPS, diluted
- -$0.14
- Book value per share
- -$1.53
- Diluted shares
- 23M
Eleven years at a glance
Fiscal years 2013 to 2026 and trailing twelve months, USD
Revenue
$16.40M+13.4% YoY
Gross profit
$13.36M+18.1% YoY
Operating income
$1.57M
Net income
-$2.69M
EPS, diluted
-$0.14
Free cash flow
–
Reported periodTrailing twelve months